Abstract. Pancreatic carcinoma is a common cancer type with a poor prognosis. The aim of the present study was to examine the expression of tumor suppressor genes phosphatase and tensin homolog deleted in chromosome 10 (PTEN) and KAI1 in pancreatic carcinoma and its association with clinical pathological factors. A total of 50 hospitalized cases of pancreatic cancer including 28 males and 22 females aged 31-82 years were included in the present study. Ten cases of normal pancreatic tissue were obtained from cadavers and served as the controls. The pancreatic specimens were embedded in paraffin blocks and slides were prepared for immunohistochemical analysis to determine the expression of PTEN and KAI1 in normal pancreatic tissue and pancreatic carcinoma samples. The positive expression rate of PTEN in the normal pancreatic tissue was higher than that in pancreatic carcinoma (P<0.05), while the positive expression rate of KAI1 in the normal pancreatic tissue was lower than that in pancreatic carcinoma (P<0.05). Pathological factors such as clinical stage of disease, histological grade and the presence or absence of lymphatic metastasis significantly affected the expression of PTEN and KAI1 (P<0.05). In conclusion, the positive expression of PTEN and KAI1 in pancreatic carcinoma is closely associated with the development of pancreatic carcinoma.
Introduction
Pancreatic carcinoma is a common type of cancer that is difficult to detect at the early stage owing to its latency and which has a poor prognosis. A possible reason for this is that phosphatase activity of tumor suppressor gene phosphatase and tensin homolog deleted in chromosome 10 (PTEN) induces immoderate growth of genes (1, 2) . The PTEN protein is widely expressed throughout the body and acts as a phosphatase for inhibition of the AKT signaling pathway. It is also one of the most commonly lost tumor suppressors in cancer. Mutations or deletions in PTEN inactivate its enzymatic activity leading to increased cell proliferation and reduced cell death (3) .
Tumor metastasis suppressor gene, KAI1, also known as CD82, has been reported to be associated with tumor metastasis and prognosis (4, 5) . KAI1 is a member of the tetraspanin family based on its structural basis and as a metastatic suppressor gene based on functional grounds. Loss of KAI1 expression is associated with advanced stages of various human malignancies and results in invasive and metastatic behavior of tumor cells.
In the present study, we investigated the expression of PTEN and KAI1 tumor suppressor genes by determining their protein expression in pancreatic carcinoma through immunohistochemistry (IHC) to evaluate the clinical significance of the proteins in pancreatic cancer progression. San Jose, CA, USA) was used. The streptavidin-peroxidase kit was purchased from CapitalBio Corporation (Beijing, China).
Materials and methods

Clinical
Histological analysis. The stained slides were analyzed as previously described (7) . The presence of brownish yellow granules was considered as a positive expression. A positive cell ratio of <10% was defined as negative, while a positive cell ratio of ≥10% was defined as positive. For KAI1 staining, the presence of brownish yellow granules in the cell membrane or cytoplasm was considered as KAI1-positive expression. A positive cell ratio of <25% was defined as negative, whereas a positive cell ratio of ≥25% was defined as positive.
Statistical analysis. SPSS 16.0 software (SPSS, Inc., Chicago, IL, USA) was used for the χ 2 test for different groups. Data were presented as mean ± standard deviation. P<0.05 was considered to indicate a statistically significant difference.
Results
PTEN expression.
The positive PTEN expression rate in normal pancreatic tissue was identified as 70.0% (7/10), which was significantly higher compared to that of pancreatic carcinoma (38.0%, 19/50) (P<0.05). In addition, a positive PTEN expression rate in pancreatic carcinoma was statistically significant for the different clinical stages, histological grade, and with or without lymphatic metastasis (Table I) .
KAI1 expression.
The positive KAI1 expression rate in normal pancreatic tissue was identified as 30.0% (3/10), which was significantly lower than that of pancreatic carcinoma (70.0%, 35/50) (P<0.05). A positive KAI1 expression rate in pancreatic carcinoma was statistically significant for the different clinical stages, histological grade, and with or without lymphatic metastasis (Table II) .
Discussion
The incidence of pancreatic cancer has been on the increase. Detection of pancreatic cancer poses a challenge in the absence of effective biomarkers. Additionally, tumor cells are also likely to migrate causing further adverse conditions. Pancreatic cancer is characterized by an increasingly high transfer rate, low excision rate, and low survival rate following surgery (8) (9) (10) . Tumor suppressor genes are important in the occurrence of pancreatic cancer (11) , although the specific underlying mechanism remains to be determined.
The most prominent characteristics of PTEN is its combined structure of phosphotyrosine phosphatase and dual specificity phosphatase (12) (13) (14) , indicating a dephosphorylation effect on phosphorylated serine or threonine and tyrosine residue, which is directly associated with tumor inhibition. A possible reason is that phosphorylation of tyrosine residues in protein may regulate cell growth and differentiation. PTEN has protein phosphatase activity, which reduces the phosphorylation level of focal adhesion kinase mediated by fibronectin and inhibits its activity, and influences the interaction among cells and between the cells and the extracellular matrix. This results in the successful inhibition of the invasion and metastasis of tumor cells (15) (16) (17) (18) . By contrast, when the expression of PTEN is reduced or when PTEN loses its negative regulation on the signal transduction pathway, pancreatic cells may not be regularly regulated, leading to excessive cell proliferation or migration to other areas. Results of the present study showed that a positive PTEN expression rate in normal pancreatic tissue was higher than that in pancreatic carcinoma. As the disease stage increased in later clinical stages (II and IV), the expression of PTEN was downregulated. These findings are consistent with the hypothesis that PTEN is important in the development or transfer of pancreatic cancer (19) (20) (21) .
The tumor metastasis suppressor gene, KAI1 is shown to be involved in cancer metastasis by enhancing the infiltration and transfer of cancer cells (22) . KAI1 has a stable translational level in pancreatic tissues (23), but has no or minimal activity in healthy pancreatic tissues. The results from the current study show that the positive expression rate of KAI1 protein in normal pancreatic tissues was lower than that in pancreatic carcinoma. Other studies have also shown that the positive expression rate of KAI1 mRNA in normal pancreatic tissues is lower than that in the primary pancreatic carcinoma (24) (25) (26) . The expression of KAI1 mRNA in advanced pancreatic carcinoma with lymphatic metastasis was significantly higher than that in the early pancreatic carcinoma (27, 28) . In the present study, we identified that the expression of KAI1 in clinically advanced pancreatic carcinoma was significantly higher than that in the clinically early pancreatic carcinoma. In addition, the expression of KAI1 in pancreatic carcinoma with high cell differentiation was significantly lower than that in pancreatic carcinoma with poor differentiation. Additionally, the expression of KAI1 in pancreatic carcinoma with lymphatic metastasis was higher than that in pancreatic carcinoma without lymphatic metastasis. The result was consistent with previous studies (27, 28) and emphasizes that KAI1 is closely associated with the occurrence, development, and transfer of pancreatic cancer.
In conclusion, clinical stages, histological grade, as well as presence or absence of lymphatic metastasis affect the positive expression of PTEN and KAI1 in pancreatic carcinoma. The two genes are closely associated with lymphatic metastasis and the degree of tumor malignancy.
